MC2050A1 - Derives de benzopyrannols,compositions pharmaceutiques les contenant et procede de fabrication - Google Patents

Derives de benzopyrannols,compositions pharmaceutiques les contenant et procede de fabrication

Info

Publication number
MC2050A1
MC2050A1 MC892067A MC2067A MC2050A1 MC 2050 A1 MC2050 A1 MC 2050A1 MC 892067 A MC892067 A MC 892067A MC 2067 A MC2067 A MC 2067A MC 2050 A1 MC2050 A1 MC 2050A1
Authority
MC
Monaco
Prior art keywords
benzopyrannol
derivatives
manufacture
pharmaceutical compositions
compositions containing
Prior art date
Application number
MC892067A
Other languages
English (en)
Inventor
Walser Armin
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of MC2050A1 publication Critical patent/MC2050A1/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/58—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
    • C07D311/70—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4 with two hydrocarbon radicals attached in position 2 and elements other than carbon and hydrogen in position 6
    • C07D311/72—3,4-Dihydro derivatives having in position 2 at least one methyl radical and in position 6 one oxygen atom, e.g. tocopherols
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/10—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
    • C07D407/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • C07D491/044—Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring
    • C07D491/048—Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring the oxygen-containing ring being five-membered
MC892067A 1988-08-09 1989-08-07 Derives de benzopyrannols,compositions pharmaceutiques les contenant et procede de fabrication MC2050A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US23009488A 1988-08-09 1988-08-09
US07/367,082 US5015661A (en) 1988-08-09 1989-06-16 Chromanes and their pharmaceutical compositions and methods

Publications (1)

Publication Number Publication Date
MC2050A1 true MC2050A1 (fr) 1990-07-17

Family

ID=26923917

Family Applications (1)

Application Number Title Priority Date Filing Date
MC892067A MC2050A1 (fr) 1988-08-09 1989-08-07 Derives de benzopyrannols,compositions pharmaceutiques les contenant et procede de fabrication

Country Status (13)

Country Link
US (1) US5015661A (fr)
EP (1) EP0354508A3 (fr)
JP (1) JPH0283379A (fr)
KR (1) KR900003175A (fr)
AU (1) AU616039B2 (fr)
DK (1) DK389089A (fr)
HU (1) HU206204B (fr)
IL (1) IL91245A0 (fr)
MC (1) MC2050A1 (fr)
NO (1) NO172643C (fr)
NZ (1) NZ230233A (fr)
PH (1) PH27235A (fr)
PT (1) PT91400A (fr)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1305480C (fr) * 1987-03-20 1992-07-21 Roshantha A.S. Chandraratna Acetylenes disubstitues portant des groupes heteroaromatiques et heterobicycliques a activite retinoidale
FR2676056B1 (fr) * 1991-05-03 1993-07-16 Adir Nouveaux derives du benzopyranne leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
US5149703A (en) * 1991-09-06 1992-09-22 Merck Frosst Canada, Inc. Quinoline-substituted chromans and related compounds as leukotriene antagonists
US5280040A (en) * 1993-03-11 1994-01-18 Zymogenetics, Inc. Methods for reducing bone loss using centchroman derivatives
US5451603A (en) * 1993-03-11 1995-09-19 Zymogenetics, Inc. 3,4-diarylchromans for treatment of dermatitis
DK0682664T3 (da) * 1993-12-08 2001-07-16 Alcon Lab Inc Forbindelser med både potent calciumantagonist og antioxiderende aktivitet og anvendelse deraf som cytobeskyttende midler
US5747528A (en) * 1996-02-21 1998-05-05 Warner-Lambert Company Chroman derivatives as anti-oxidants
ITTO20030140U1 (it) * 2003-09-16 2005-03-17 Interfila Srl Matita cosmetica
US20050065099A1 (en) 2003-09-19 2005-03-24 Gail Walkinshaw Treatment of mitochondrial diseases
MX2007007103A (es) * 2004-12-13 2008-03-10 Lilly Co Eli Derivados espiro como inhibidores de lipoxigenasa.
US20080207588A1 (en) 2005-02-25 2008-08-28 Chu Daniel T W Spiro-Heterocyclic Chromans, Thiochromans and Dihydroquinolines

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6051189A (ja) * 1983-08-30 1985-03-22 Sankyo Co Ltd チアゾリジン誘導体およびその製造法
US4681890A (en) * 1984-10-30 1987-07-21 Kuraray Co., Ltd. 3,4-dihydrobenzopyran compounds and pharmaceutical composition containing the same
EP0183869B1 (fr) * 1984-12-06 1991-04-17 Kuraray Co., Ltd. Composés de chromane et leur utilisation
JPS61148173A (ja) * 1984-12-20 1986-07-05 Kuraray Co Ltd 新規なアミン及びその塩
DK173350B1 (da) * 1985-02-26 2000-08-07 Sankyo Co Thiazolidinderivater, deres fremstilling og farmaceutisk paæparat indeholdende dem
JPS61204122A (ja) * 1985-03-07 1986-09-10 Kuraray Co Ltd 肝臓疾患治療剤
JPS61210030A (ja) * 1985-03-13 1986-09-18 Agency Of Ind Science & Technol 抗腫瘍剤
JPS61267570A (ja) * 1985-05-20 1986-11-27 Kuraray Co Ltd ３，４―ジヒドロ―２ｈ―ベンゾピラン誘導体及びこれを有効成分とする利胆剤
JPS61267571A (ja) * 1985-05-20 1986-11-27 Kuraray Co Ltd ２−（４−クロルフエノキシ）−２−メチルプロピオン酸エステル及びこれを有効成分とする血中脂質低下剤
JPS62132879A (ja) * 1985-12-05 1987-06-16 Kuraray Co Ltd ３，４−ジヒドロ−２ｈ−ベンゾピラン誘導体類及びこれを有効成分とする抗アレルギ−剤
US4752646A (en) * 1986-01-23 1988-06-21 Hoffmann-La Roche Inc. 2-halochromans
US4824971A (en) * 1986-01-23 1989-04-25 Hoffman-La Roche Inc. 2-allylchromans
WO1987005020A1 (fr) * 1986-02-21 1987-08-27 Kuraray Co., Ltd. Derives de 3,4-dihydro-2h-benzopyranne et leur usage medicinal
US4879395A (en) * 1987-03-27 1989-11-07 Hoffmann-La Roche Inc. Vitamin E intermediate
US4914217A (en) * 1987-12-18 1990-04-03 Hoffmann-La Roche Inc. Asymmetric synthesis of natural vitamin E
US4831185A (en) * 1987-12-18 1989-05-16 Hoffmann-La Roche Inc. Asymmetric synthesis of natural vitamin E

Also Published As

Publication number Publication date
NO172643B (no) 1993-05-10
HUT52493A (en) 1990-07-28
AU3941889A (en) 1990-02-15
KR900003175A (ko) 1990-03-23
NO893198D0 (no) 1989-08-08
NO172643C (no) 1993-08-18
PH27235A (en) 1993-05-04
DK389089D0 (da) 1989-08-08
NO893198L (no) 1990-02-12
US5015661A (en) 1991-05-14
EP0354508A2 (fr) 1990-02-14
PT91400A (pt) 1990-03-08
DK389089A (da) 1990-02-10
NZ230233A (en) 1992-03-26
HU206204B (en) 1992-09-28
EP0354508A3 (fr) 1991-03-27
JPH0283379A (ja) 1990-03-23
IL91245A0 (en) 1990-03-19
JPH0579072B2 (fr) 1993-11-01
AU616039B2 (en) 1991-10-17

Similar Documents

Publication Publication Date Title
FR2598706B1 (fr) Derives de tetrahydronaphtalene, compositions pharmaceutiques les contenant et procede de preparation
FR2466248B1 (fr) Derives d'agents anti-inflammatoires non steroides, procede de preparation et compositions pharmaceutiques les contenant
PT78340B (fr) Procede de preparation de nouveaux derives de la tetrahydroxy- 3',4',5,7-flavone et des compositions pharmaceutiques les contenant
PT85279A (fr) Procede de preparation de derives du nitrofurane et de compositions pharmaceutiques les contenant
PT77488A (fr) Procede de preparation de derives de phenyl-1-piperidino-2-propanol et de compositions pharmaceutiques les contenant
PT81310A (fr) Procede de preparation de derives de piperidine et de compositions pharmaceutiques les contenant
PT80921A (fr) Procede de preparation de derives d'acylaminomethyl-3-imidazo<1,2-a>pyridines et de compositions pharmaceutiques les contenant
FR2636628B1 (fr) Derives du thiadiazole-1,3,4, leur procede d'obtention et compositions pharmaceutiques en contenant
PT83355A (fr) Procede de preparation de derives de benzimidazole et de compositions pharmaceutiques les contenant
PT83896A (fr) Procede pour la preparation de nouveaux conjuges de la vinblas-tine et de ses derives et de compositions pharmaceutiques les contenant
MC2050A1 (fr) Derives de benzopyrannols,compositions pharmaceutiques les contenant et procede de fabrication
PT83593A (fr) Procede de preparation de 7-acyl-benzoxazinones et leurs derives et de compositions pharmaceutiques les contenant
PT79365A (fr) Procede de preparation de derives d'imidazoline et de compositions pharmaceutiques les contenant
PT74651A (fr) Procede de preparation de derives de pyridine et de compositions pharmaceutiques les contenant
PT82364B (fr) Procede de preparation de derives du nitrofuranne et de compositions pharmaceutiques les contenant
FR2582835B1 (fr) Derives de la quinoleine, leur procede de preparation et compositions pharmaceutiques les contenant
FR2571369B1 (fr) Derives de la vitamine d et precurseurs de ceux-ci et compositions pharmaceutiques en contenant
FR2615188B1 (fr) Derives d'hydrazine, procede d'obtention et compositions pharmaceutiques les contenant
PT77751A (fr) Procede de preparation de derives benzylideniques soufres et de compositions pharmaceutiques le contenant
PT75868A (fr) Procede de preparation de derives benzylideniques et de compositions pharmaceutiques les contenant
IT8103423A0 (it) Derivati di alcandioli conattivita' ipolipidemizzante, metodi per la loro preparazione e composizioni farmaceutiche che licontengono
PT78272A (fr) Procede de preparation de derives d'(indenyl-2)-2 imidazole et de compositions pharmaceutiques les contenant
FR2649981B1 (fr) Derives de dihydropyrimidothiazine, leur procede de preparation et compositions pharmaceutiques les contenant
PT84883A (fr) Procede de preparation de nouveaux derives nicotiniques et de compositions fongicides les contenant
PT78428A (fr) Procede de preparation de diphenylazomethines et de compositi- ons pharmaceutiques les contenant

Legal Events

Date Code Title Description
YP Annual fee paid